HTG Molecular Diagnostics, Inc.
HTGMQ
$0.0001
$0.000.00%
| Weiss Ratings | HTGMQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | HTGMQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | HTGMQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -47.10 | |||
| Price History | HTGMQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -75.00% | |||
| 90-Day Total Return | -75.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -96.00% | |||
| 2-Year Total Return | -100.00% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -100.00% | |||
| 52-Week High % Change | -99.90% | |||
| 52-Week Low % Change | 9,900.00% | |||
| Price | HTGMQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.10 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Dec 18, 2024 | |||
| 52-Week High Price (Date) | May 23, 2024 | |||
| Valuation | HTGMQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 221.00 | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -18.08 | |||
| Earnings Per Share Growth | -39.53% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | HTGMQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 2.21M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HTGMQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 877 289 2615 | |||
| Address | 3430 East Global Loop Tucson, AZ 85706 | |||
| Website | www.htgmolecular.com | |||
| Country | United States | |||
| Year Founded | 1997 | |||
| Profitability | HTGMQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -316.88% | |||
| Profit Margin | -324.27% | |||
| Management Effectiveness | HTGMQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -62.59% | |||
| Return on Equity | -- | |||
| Income Statement | HTGMQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 6.21M | |||
| Total Revenue (TTM) | 6.21M | |||
| Revenue Per Share | $2.81 | |||
| Gross Profit (TTM) | -5.13M | |||
| EBITDA (TTM) | -19.20M | |||
| EBIT (TTM) | -19.69M | |||
| Net Income (TTM) | -20.15M | |||
| Net Income Avl. to Common (TTM) | -20.15M | |||
| Total Revenue Growth (Q YOY) | -12.83% | |||
| Earnings Growth (Q YOY) | 22.20% | |||
| EPS Diluted (TTM) | -18.08 | |||
| EPS Diluted Growth (Q YOY) | 76.54% | |||
| Balance Sheet | HTGMQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 6.56M | |||
| Cash Per Share (Q) | $2.96 | |||
| Total Current Assets (Q) | 9.19M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 474.50K | |||
| Current Ratio (Q) | 1.401 | |||
| Book Value Per Share (Q) | $0.21 | |||
| Total Assets (Q) | 10.87M | |||
| Total Current Liabilities (Q) | 6.56M | |||
| Total Debt (Q) | 7.80M | |||
| Total Liabilities (Q) | 10.39M | |||
| Total Common Equity (Q) | 474.50K | |||
| Cash Flow | HTGMQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 3.48M | |||
| Cash from Financing (TTM) | 1.73M | |||
| Net Change in Cash (TTM) | -11.62M | |||
| Levered Free Cash Flow (TTM) | -9.98M | |||
| Cash from Operations (TTM) | -16.83M | |||
